Nectar Lifescience Ltd.
BSE: 532649 | Sector: Health care |
NSE: NECLIFE | ISIN Code: INE023H01027 |
BSE 00:00 | 20 Apr | 27.50 |
-0.05 (-0.18%) |
OPEN
27.50 |
HIGH
27.70 |
LOW
27.35 |
NSE 00:00 | 20 Apr | 27.40 |
-0.25 (-0.90%) |
OPEN
27.25 |
HIGH
27.80 |
LOW
27.20 |
OPEN | 27.50 |
PREVIOUS CLOSE | 27.55 |
VOLUME | 19720 |
52-Week high | 43.65 |
52-Week low | 24.00 |
P/E | 10.87 |
Mkt Cap.(Rs cr) | 617 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Filter:
Nectar Lifescience Ltd. (NECLIFE) - Cash Flow
Figures in Rs crore | 2017 | 2016 | 2015 |
Opening Cash & Cash Equivalents | 36.41 | 33.38 | 9.98 |
Net Cash From Operating Activities | 198.62 | 168.91 | 144.41 |
Net Cash Used In/from Investing Activities | -18.11 | -77.21 | -59.53 |
Net Cash Used In/from Financing Activities | -204.12 | -88.68 | -61.47 |
Net (decrease)/increase In Cash and Cash Equivalents |
-23.60 | 3.03 | 23.41 |
Closing Cash & Cash Equivalents | 12.81 | 36.41 | 33.38 |
Quick Links for Nectar Lifescience:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices